OncoGxOne™ is a more comprehensive test that analyzes a patient’s tumor for genetic mutations in 56 cancer-related genes and 8 genes (64 genes total) related to pharmacogenomics, with coverage of clinically actionable alterations found in multiple cancer types, such as those involving the breast, lower GI (colorectal), upper GI (esophagus, GIST), non-small cell lung cancer (NSCLC) thyroid, and melanoma, brain, blood (leukemias), lymph nodes (lymphomas), muscle, ovarian, fat (liposarcoma), prostate, urinary bladder, thymus, etc.

[ 64 Genes ]

OncoGxOne™ Gene List: